|
Originally published In Press as doi:10.1074/jbc.M403690200 on May 15, 2004
J. Biol. Chem., Vol. 279, Issue 29, 30189-30194, July 16, 2004
A Maternal Ahr Null Genotype Sensitizes Embryos to Chemical Teratogenesis*
Tami L. Thomae,
Edward Glover, and
Christopher A. Bradfield
From the
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706
The aryl hydrocarbon receptor (encoded by the Ahr locus) is a ligand-activated transcription factor that mediates the toxicology and teratology of 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin). In an effort to understand the role of the maternal compartment in dioxin teratology, we designed a breeding strategy that allowed us to compare the teratogenic response in embryos from Ahr/ (null) and Ahr+/+ (wild-type) dams. Using this strategy, we demonstrate that embryos from the Ahr/ dams are 5-fold more sensitive to dioxin-induced cleft palate and hydronephrosis as compared with embryos from an Ahr+/+ dam. Moreover, this increased teratogenic sensitivity extends beyond dioxin, because embryos from Ahr/ dams exhibited a 9-fold increase in their sensitivity to the fetotoxic effects of the glucocorticoid, dexamethasone. In searching for an explanation for this increased sensitivity, we found that more dioxin and dexamethasone reached the embryos from Ahr/ dams as compared with embryos from Ahr+/+ dams. We propose that increased deposition of teratogens/fetotoxicants to the embryonic compartment is the result of porto-systemic shunting and/or blocked P4501A induction in Ahr/ dams. In addition to demonstrating the importance of maternal AHR in teratogenesis, these data may have implications that reach beyond the mechanism of action of dioxin. In this regard, the Ahr/ mouse may provide a system that allows pharmacological agents and toxicants to be more easily studied in a model where first pass clearance is a significant obstacle.
Received for publication, April 2, 2004
, and in revised form, May 10, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should addressed: McArdle Laboratory for Cancer Research, 1400 University Ave., Madison, WI 53706-1599. Tel.: 608-262-2024; Fax: 608-262-2824; E-mail: Bradfield{at}oncology.wisc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. C. Lin, L. P. Nguyen, J. A. Walisser, and C. A. Bradfield
A Hypomorphic Allele of Aryl Hydrocarbon Receptor-Associated Protein-9 Produces a Phenocopy of the Ahr-Null Mouse
Mol. Pharmacol.,
November 1, 2008;
74(5):
1367 - 1371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Bell, S. Clode, M. Q. Fan, A. Fernandes, P. M. D. Foster, T. Jiang, G. Loizou, A. MacNicoll, B. G. Miller, M. Rose, et al.
Relationships between Tissue Levels of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), mRNAs, and Toxicity in the Developing Male Wistar(Han) Rat
Toxicol. Sci.,
October 1, 2007;
99(2):
591 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. McMillan and C. A. Bradfield
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
Mol. Pharmacol.,
September 1, 2007;
72(3):
487 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci.,
July 1, 2007;
98(1):
5 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dragin, T. P. Dalton, M. L. Miller, H. G. Shertzer, and D. W. Nebert
For Dioxin-induced Birth Defects, Mouse or Human CYP1A2 in Maternal Liver Protects whereas Mouse CYP1A1 and CYP1B1 Are Inconsequential
J. Biol. Chem.,
July 7, 2006;
281(27):
18591 - 18600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Harstad, C. A. Guite, T. L. Thomae, and C. A. Bradfield
Liver Deformation in Ahr-Null Mice: Evidence for Aberrant Hepatic Perfusion In Early Development
Mol. Pharmacol.,
May 1, 2006;
69(5):
1534 - 1541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Thomae, E. A. Stevens, A. L. Liss, N. R. Drinkwater, and C. A. Bradfield
The Teratogenic Sensitivity to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Modified by a Locus on Mouse Chromosome 3
Mol. Pharmacol.,
March 1, 2006;
69(3):
770 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K P Lai, M H Wong, and C K C Wong
Inhibition of CYP450scc expression in dioxin-exposed rat Leydig cells
J. Endocrinol.,
June 1, 2005;
185(3):
519 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Walisser, M. K. Bunger, E. Glover, and C. A. Bradfield
Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development
PNAS,
November 23, 2004;
101(47):
16677 - 16682.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|